Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

AstraZeneca has held internal talks for Medivation bid - Sunday Times

Published 18/04/2016, 03:20
© Reuters. A sign is seen at an AstraZeneca site in Macclesfield
JPM
-
SASY
-
AZN
-
MDVN
-

(Reuters) - Drugmaker AstraZeneca Plc (L:AZN) has held internal talks about a bid for cancer treatment maker Medivation Inc (O:MDVN) but has yet to make a formal offer, the Sunday Times reported, citing sources.

AstraZeneca has been looking at Medivation for the past six months and is looking very closely at making an offer, the newspaper said, citing sources and a senior healthcare banker.

In March, Reuters reported that Medivation had been working with investment bank JPMorgan Chase & Co (N:JPM) to handle interest from other companies in a potential acquisition, but it had no plans to sell itself.

San Francisco based-Medivation, which has a market capitalisation of $8.4 billion (5.92 billion pounds), focuses on cancer treatment drugs.

Less than a week ago, the company rebuffed a takeover bid from French drugmaker Sanofi SA (PA:SASY), Bloomberg reported.

© Reuters. A sign is seen at an AstraZeneca site in Macclesfield

AstraZeneca and Medivation said they do not comment on rumors or speculation.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.